You've almost certainly heard of them. Ozempic, Wegovy, Mounjaro, Zepbound — the GLP-1 receptor agonist drugs have dominated health news for the better part of three years. They work. That part is not in dispute. Clinical trials show average weight loss of 15 to 22 percent of body weight — numbers that the medical field hasn't seen from any obesity medication before.
But the conversation in doctors' offices and online tends to focus on younger, middle-aged adults. For people over 60, the picture is more nuanced, and the questions that matter most are different.
How These Drugs Work
GLP-1 (glucagon-like peptide-1) is a hormone your gut naturally produces after eating. It signals fullness to the brain, slows digestion, and prompts insulin release. GLP-1 drugs mimic this hormone at much higher levels than your body produces naturally, which dramatically reduces appetite and slows how quickly food leaves the stomach.
Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) are the two most widely used. Ozempic is FDA-approved for type 2 diabetes management; Wegovy is FDA-approved specifically for weight loss. Mounjaro is approved for diabetes; Zepbound for obesity. The drugs are often prescribed interchangeably off-label.
What Medicare Covers — and What It Doesn't
This is where many seniors run into a hard wall. Traditional Medicare Part D covers GLP-1 drugs for type 2 diabetes management, but not for weight loss alone. Federal law has long excluded weight loss drugs from Medicare coverage.
If you have type 2 diabetes and your doctor prescribes Ozempic for blood sugar management, Part D will typically cover it after meeting your deductible. If you're seeking it solely for weight loss, original Medicare will not cover it, regardless of your BMI.
Medicare Advantage plans have more flexibility, and some do cover weight loss medications — but this varies considerably by plan and has changed from year to year. During open enrollment, it's worth specifically asking whether your plan covers GLP-1 medications for weight management.
Without insurance, these drugs run approximately $900 to $1,300 per month at retail price.
The Specific Concerns for Older Adults
For adults over 60, doctors and researchers are paying close attention to several issues that matter less in younger patients.
Muscle and bone loss. When people lose significant weight quickly, they lose not only fat but also lean muscle mass — a phenomenon called sarcopenia that's already a concern for older adults independently of weight loss. Studies of GLP-1 users have found that a meaningful portion of weight lost is lean mass. In older adults, this can accelerate age-related muscle decline and increase the risk of falls and fractures. Many geriatricians now recommend high protein intake (1.2–1.5 grams per kilogram of body weight daily) and resistance training for any older adult taking these medications.
Nutritional adequacy. These drugs suppress appetite significantly. For older adults who may already eat less than optimal amounts, this can tip into actual nutritional deficiency if eating is reduced too much. Your doctor should monitor weight loss rate, protein intake, and micronutrient levels.
Drug interactions. Older adults typically take more medications than younger people. GLP-1 drugs can affect the absorption timing of oral medications because they slow gastric emptying. This is particularly relevant for thyroid medications and oral diabetes drugs.
The cardiovascular benefit. One finding from the large SELECT trial — a cardiovascular outcomes study of semaglutide in people with established heart disease — was encouraging: it showed a 20 percent reduction in major cardiovascular events like heart attack and stroke. For older adults with cardiovascular disease who are also overweight, this adds a meaningful dimension to the risk-benefit calculation.
Questions Worth Asking Your Doctor
If you're considering asking your doctor about these medications, these are the most important questions to raise:
- Am I a good candidate given my other conditions and medications?
- What will you monitor — and how often — while I'm on it?
- What protein intake and physical activity should I maintain?
- Does my Medicare plan cover this, and if so, for what indication?
- What are the realistic expectations for someone my age?
The National Institute on Aging and the CDC continue to monitor the long-term data on these drugs in older populations. For now, the consensus in geriatric medicine is that they can be appropriate for carefully selected older adults — with close monitoring and intentional attention to maintaining muscle mass.